Many Top U.S. Researchers Are Disenchanted With Big Science

The scientists talked about their concerns, goals, and priorities for the coming year, among other topics. In a nutshell, all are worried about funding shortfalls. They also say 1991 will bring the U.S. face-to-face with critical choices about science education and the country's overall research efforts. As the federal government pumps millions of research dollars into a handful of megaprograms, hundreds of smaller, more important research initiatives are falling by the wayside, they say. Shou

Written byJulia King
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

As the federal government pumps millions of research dollars into a handful of megaprograms, hundreds of smaller, more important research initiatives are falling by the wayside, they say. Should this trend continue, many of the country's brightest young people will continue to spurn careers in scientific research for more stable and lucrative professions. Meanwhile, those students who do choose science will be forced to pursue an ever-narrowing scope of research problems deemed bankable by funding agencies.

But the picture isn't totally bleak. Despite scientists' gloom over funding shortfalls and their nearly unanimous disenchantment with big science, most say there has never been a more exciting time in science than now. Rapid advances in several disciplines--most notably neuroscience and molecular biology--have opened up entirely new areas of research, they say. But in order for such advances to continue, 1991's top science priorities must include attracting young talent to the science professions, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies